Chemical Bank’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,561
Closed -$856K 373
2016
Q4
$856K Buy
11,561
+11
+0.1% +$824 0.1% 180
2016
Q3
$873K Sell
11,550
-37
-0.3% -$2.83K 0.12% 159
2016
Q2
$892K Sell
11,587
-318
-3% -$25.1K 0.12% 158
2016
Q1
$929K Sell
11,905
-477
-4% -$33.3K 0.13% 149
2015
Q4
$837K Sell
12,382
-365
-3% -$25.5K 0.12% 164
2015
Q3
$986K Buy
12,747
+595
+5% +$52.7K 0.14% 151
2015
Q2
$1.1M Buy
12,152
+1,324
+12% +$106K 0.15% 148
2015
Q1
$815K Buy
10,828
+684
+7% +$49.1K 0.11% 180
2014
Q4
$744K Buy
10,144
+1,121
+12% +$78.8K 0.1% 189
2014
Q3
$636K Buy
+9,023
New +$596K 0.11% 176

Other funds holding HCA

Chemical Bank's HCA Position: Q1 2017 in Review

Chemical Bank sold out of HCA Healthcare (HCA) in Q1 2017, closing a stake of 11,561 shares — an estimated $856K sold.

Chemical Bank first reported a position in HCA in Q3 2014 and held it in 10 quarters. The position peaked at $1.1M in Q2 2015. 575 funds tracked by Wall St. Rank hold HCA as of Q1 2017.

  • Chemical Bank reported no remaining HCA Healthcare position as of Q1 2017 after selling out during the quarter.
  • Chemical Bank sold 11,561 HCA Healthcare shares in Q1 2017, an estimated $856K.
  • Chemical Bank first reported a position in HCA Healthcare in Q3 2014 and held it in 10 quarters.
  • Chemical Bank's HCA Healthcare position peaked at $1.1M in Q2 2015.
  • 575 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2017.

Based on Chemical Bank's 13F filing for Q1 2017, filed 15 May 2017.